Cancer research gets $39m injection
Emerging and cutting-edge cancer research will receive $39 million in funding to attract the best and brightest researchers to NSW.
Recipients of the grants will investigate a range of cancer-related areas including prevention and treatment of cancer through intermittent fasting, possible new delivery methods for DNA chemotherapeutics and a clinical trial program to prevent and treat HIV-associated cancers.
“By having the best researchers here in NSW, we are ensuring that people with cancer have the best access to new and available treatments.”
- Over $9.5 million to support the careers of cancer researchers
- A $3.8 million investment in research infrastructure
- $25.9 million to support the state’s translational cancer research centres to advance research from bench to bedside.
View the full list of funding recipients (PDF 221KB).